1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Blood-Based Biomarkers of Alzheimer’s disease: Bringing plasma p-Tau to the Clinic
(2026) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
- 2025
-
Mark
Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort
- Contribution to journal › Article
-
Mark
A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals : implications for clinical trials
- Contribution to journal › Article
-
Mark
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study
- Contribution to journal › Article
-
Mark
A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests
- Contribution to journal › Article
-
Mark
Influence of ethnicity on the diagnostic accuracy of plasma p-tau217 for the identification of Alzheimer's disease : A consecutive mixed memory clinic cohort study
- Contribution to journal › Article
-
Mark
Cell-weighted polygenic risk scores are associated with β-amyloid and tau biomarkers in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Plasma p-tau217 correlates strongly with cerebrospinal fluid Aβ42 and increases over a ten-year period in amyloid-positive, non-demented very old men
- Contribution to journal › Article
-
Mark
Combining plasma p-tau217 and cross-cultural cognitive tests to identify Alzheimer's Disease in an ethnically diverse mixed memory clinic cohort
- Contribution to journal › Article
